Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer
Hans‐Joachim Lück, Kristina Lübbe, Mattea Reinisch(German Breast group), Nicolaì Maass, Gabriele Feisel-Schwickardi(Klinikum Kassel), Oliver Tomé(St. Vincentius-Kliniken), Wolfgang Janni(University Hospital Ulm), Mustafa Aydoğdu(Klinikum Bremen-Mitte), Tanja Neunhöffer(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Angelika Ober(St. Vincenz-Krankenhaus Limburg), Bahriye Aktas(Essen University Hospital), Tjoung‐Won Park‐Simon(Medizinische Hochschule Hannover), Claudia Schumacher(St. Elisabeth-Hospital Bochum), Heinz‐Gert Höffkes(Klinikum Fulda), Thomas Illmer, H. Wagner, Keyur Mehta(German Breast group), Gϋnter von Minckwitz(German Breast group), Valentina Nekljudova(German Breast group), Sibylle Loibl(German Breast group)
Cited by 22
Abstract
Related Papers
No related papers found
Powered by citation graph analysis